Alexei Gogolev
Stock Analyst at JP Morgan
(3.64)
# 815
Out of 5,152 analysts
96
Total ratings
52.11%
Success rate
7.06%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $330 → $296 | $196.06 | +50.97% | 2 | Feb 20, 2026 | |
| PHR Phreesia | Maintains: Overweight | $29 → $24 | $12.08 | +98.68% | 2 | Feb 20, 2026 | |
| DOCS Doximity | Maintains: Neutral | $40 → $33 | $26.07 | +26.58% | 3 | Feb 20, 2026 | |
| INTA Intapp | Maintains: Overweight | $70 → $58 | $28.28 | +105.09% | 4 | Feb 4, 2026 | |
| PTC PTC Inc. | Downgrades: Underweight | $205 → $162 | $164.25 | -1.37% | 2 | Feb 2, 2026 | |
| APPF AppFolio | Maintains: Overweight | $330 → $300 | $189.90 | +57.98% | 5 | Jan 30, 2026 | |
| VRSN VeriSign | Maintains: Neutral | $270 → $271 | $238.70 | +13.53% | 2 | Jan 6, 2026 | |
| IOT Samsara | Maintains: Neutral | $46 → $48 | $29.58 | +62.27% | 5 | Dec 5, 2025 | |
| PEGA Pegasystems | Maintains: Overweight | $65 → $74 | $47.30 | +56.45% | 1 | Dec 5, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $126 → $129 | $79.96 | +61.34% | 1 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $23.54 | +10.45% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $39.51 | +29.08% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $200 | $93.13 | +114.75% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $189 → $166 | $92.94 | +78.61% | 5 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $75.48 | +24.54% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $101 | $48.91 | +106.50% | 6 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $160.84 | +79.06% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $59.27 | +43.41% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $16.50 | +172.73% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $12.13 | -9.32% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $365.87 | +43.77% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $3.70 | +764.86% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $8.52 | +228.64% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $144.58 | +72.22% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $53.18 | +3.42% | 4 | Mar 11, 2020 |
Veeva Systems
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $196.06
Upside: +50.97%
Phreesia
Feb 20, 2026
Maintains: Overweight
Price Target: $29 → $24
Current: $12.08
Upside: +98.68%
Doximity
Feb 20, 2026
Maintains: Neutral
Price Target: $40 → $33
Current: $26.07
Upside: +26.58%
Intapp
Feb 4, 2026
Maintains: Overweight
Price Target: $70 → $58
Current: $28.28
Upside: +105.09%
PTC Inc.
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $164.25
Upside: -1.37%
AppFolio
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $189.90
Upside: +57.98%
VeriSign
Jan 6, 2026
Maintains: Neutral
Price Target: $270 → $271
Current: $238.70
Upside: +13.53%
Samsara
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $29.58
Upside: +62.27%
Pegasystems
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $47.30
Upside: +56.45%
HealthEquity
Dec 4, 2025
Maintains: Overweight
Price Target: $126 → $129
Current: $79.96
Upside: +61.34%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $23.54
Upside: +10.45%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $39.51
Upside: +29.08%
Oct 31, 2025
Maintains: Overweight
Price Target: $222 → $200
Current: $93.13
Upside: +114.75%
Aug 6, 2025
Maintains: Neutral
Price Target: $189 → $166
Current: $92.94
Upside: +78.61%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $75.48
Upside: +24.54%
Jul 23, 2025
Maintains: Overweight
Price Target: $87 → $101
Current: $48.91
Upside: +106.50%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $160.84
Upside: +79.06%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $59.27
Upside: +43.41%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $16.50
Upside: +172.73%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $12.13
Upside: -9.32%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $365.87
Upside: +43.77%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $3.70
Upside: +764.86%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $8.52
Upside: +228.64%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $144.58
Upside: +72.22%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $53.18
Upside: +3.42%